Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

Research output: Contribution to journalReviewResearchpeer-review

  1. Genomic landscape of treatment refractory metastatic colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Management of late adverse effects after chemoradiation for anal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Reduction mammoplasty and mastopexy in the previously irradiated breast–a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Factors associated with melanoma-related limb lymphoedema

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Capsular contracture in patients with prior breast augmentation undergoing breast conserving therapy and irradiation

    Research output: Contribution to journalReviewResearchpeer-review

  4. Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Electrochemotherapy is now in routine clinical use to treat cutaneous metastases of any histology, and is listed in national and international guidelines for cutaneous metastases and primary skin cancer. Electrochemotherapy is used by dermatologists, surgeons, and oncologists, and for different degrees and manifestations of metastases to skin and primary skin tumours not amenable to surgery. This treatment utilises electric pulses to permeabilize cell membranes in tumours, thus allowing a dramatic increase of the cytotoxicity of anti-cancer agents. Response rates, often after only one treatment, are very high across all tumour types. The most frequent indications are cutaneous metastases from malignant melanoma and breast cancer. In 2006, standard operating procedures (SOPs) were written for this novel technology, greatly facilitating introduction and dissemination of the therapy. Since then considerable experience has been obtained treating a wider range of tumour histologies and increasing size of tumours which was not originally thought possible. A pan-European expert panel drawn from a range of disciplines from dermatology, general surgery, head and neck surgery, plastic surgery, and oncology met to form a consensus opinion to update the SOPs based on the experience obtained. This paper contains these updated recommendations for indications for electrochemotherapy, pre-treatment information and evaluation, treatment choices, as well as follow-up.

Original languageEnglish
JournalActa oncologica
Volume57
Issue number7
Pages (from-to)874-882
Number of pages9
ISSN0284-186X
DOIs
Publication statusPublished - Jul 2018

    Research areas

  • Consensus, Electrochemotherapy/methods, Humans, Melanoma/drug therapy, Practice Guidelines as Topic, Reference Standards, Skin Neoplasms/drug therapy

ID: 56581811